Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Rowley

Showing results (161-170 of 208) with videos related to

Pageof 21
Sort By:
BMC Research Notes|July 24, 2020
Molecular comparison of pure ovarian fibroma with serous benign ovarian tumoursSally M Hunter, Genevieve V Dall, Maria A Doyle, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|October 8, 2010
The metabolism and disposition of a potent inhibitor of hepatitis C virus NS3/4A proteaseE Monteagudo, M Fonsi, X Chu, et al.
Journal of Fish Diseases|September 8, 2009
Prospective longitudinal studies of salmonid alphavirus infections on two Atlantic salmon farms in Ireland; evidence for viral persistenceD A Graham, E Fringuelli, C Wilson, et al.
The Journal of Pathology|October 26, 2012
RNF43 is a tumour suppressor gene mutated in mucinous tumours of the ovaryGeorgina L Ryland, Sally M Hunter, Maria A Doyle, et al.
Journal of Medicinal Chemistry|May 13, 1994
3'-(Arylmethyl)- and 3'-(aryloxy)-3-phenyl-4-hydroxyquinolin-2(1H)-ones: orally active antagonists of the glycine site on the NMDA receptorJ J Kulagowski, R Baker, N R Curtis, et al.
Bioorganic & Medicinal Chemistry|July 29, 1998
3-(1-piperazinyl)-4,5-dihydro-1H-benzo[g]indazoles: high affinity ligands for the human dopamine D4 receptor with improved selectivity over ion channelsI Collins, M Rowley, W B Davey, et al.
Nature Communications|April 4, 2020
Exome sequencing of familial high-grade serous ovarian carcinoma reveals heterogeneity for rare candidate susceptibility genesDeepak N Subramanian, Magnus Zethoven, Simone McInerny, et al.
Plos One|April 27, 2012
MicroRNA genes and their target 3'-untranslated regions are infrequently somatically mutated in ovarian cancersGeorgina L Ryland, Jennifer L Bearfoot, Maria A Doyle, et al.
NPJ Genomic Medicine|January 10, 2025
Assessment of candidate high-grade serous ovarian carcinoma predisposition genes through integrated germline and tumour sequencingDeepak N Subramanian, Maia Zethoven, Kathleen I Pishas, et al.
Bioorganic & Medicinal Chemistry|December 5, 1998
Substituted pyrazoles as novel selective ligands for the human dopamine D4 receptorS Bourrain, I Collins, J G Neduvelil, et al.
Pageof 21

Showing results (161-170 of 208) with videos related to

Sort By:
Pageof 21
BMC Research Notes|July 24, 2020
Molecular comparison of pure ovarian fibroma with serous benign ovarian tumoursSally M Hunter, Genevieve V Dall, Maria A Doyle, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|October 8, 2010
The metabolism and disposition of a potent inhibitor of hepatitis C virus NS3/4A proteaseE Monteagudo, M Fonsi, X Chu, et al.
Journal of Fish Diseases|September 8, 2009
Prospective longitudinal studies of salmonid alphavirus infections on two Atlantic salmon farms in Ireland; evidence for viral persistenceD A Graham, E Fringuelli, C Wilson, et al.
The Journal of Pathology|October 26, 2012
RNF43 is a tumour suppressor gene mutated in mucinous tumours of the ovaryGeorgina L Ryland, Sally M Hunter, Maria A Doyle, et al.
Journal of Medicinal Chemistry|May 13, 1994
3'-(Arylmethyl)- and 3'-(aryloxy)-3-phenyl-4-hydroxyquinolin-2(1H)-ones: orally active antagonists of the glycine site on the NMDA receptorJ J Kulagowski, R Baker, N R Curtis, et al.
Bioorganic & Medicinal Chemistry|July 29, 1998
3-(1-piperazinyl)-4,5-dihydro-1H-benzo[g]indazoles: high affinity ligands for the human dopamine D4 receptor with improved selectivity over ion channelsI Collins, M Rowley, W B Davey, et al.
Nature Communications|April 4, 2020
Exome sequencing of familial high-grade serous ovarian carcinoma reveals heterogeneity for rare candidate susceptibility genesDeepak N Subramanian, Magnus Zethoven, Simone McInerny, et al.
Plos One|April 27, 2012
MicroRNA genes and their target 3'-untranslated regions are infrequently somatically mutated in ovarian cancersGeorgina L Ryland, Jennifer L Bearfoot, Maria A Doyle, et al.
NPJ Genomic Medicine|January 10, 2025
Assessment of candidate high-grade serous ovarian carcinoma predisposition genes through integrated germline and tumour sequencingDeepak N Subramanian, Maia Zethoven, Kathleen I Pishas, et al.
Bioorganic & Medicinal Chemistry|December 5, 1998
Substituted pyrazoles as novel selective ligands for the human dopamine D4 receptorS Bourrain, I Collins, J G Neduvelil, et al.
Pageof 21